7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

TransCode Therapeutics Inc
(NASDAQ:RNAZ) 

RNAZ stock logo

TransCode Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for treating metastatic disease. The Company's development pipeline includes TTX-MC138, TTX-siPD-L1 and TTX-RIGA, TTX-siLIN28B, and TCD-miR10b.

Founded: 2016
CEO / Co-Founder: Michael Dudley 
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

Share this website to your friends
TransCode Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0623.441,246.871,870.312,493.743,117.183,740.614,364.05
TransCode Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -28.81-24.69-20.58-16.46-12.35-8.23-4.120
TransCode Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -28.86-24.74-20.62-16.49-12.37-8.25-4.120
TransCode Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.631.261.892.523.153.784.41
TransCode Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.81-1.55-1.29-1.03-0.77-0.52-0.260
TransCode Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -240.22-205.72-171.23-136.73-102.24-67.75-33.251.24
No extra charts and metrics for this ticker.